BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37371693)

  • 1. Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment.
    Daglish SCD; Fennell EMJ; Graves LM
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alternative Proteolysis during Import.
    Nouws J; Goswami AV; Bestwick M; McCann BJ; Surovtseva YV; Shadel GS
    J Biol Chem; 2016 Jan; 291(2):989-97. PubMed ID: 26586915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
    Li SP; Ou L; Zhang Y; Shen FR; Chen YG
    Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.
    Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T
    Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer.
    Yu HJ; Xiao GL; Zhao YY; Wang XX; Lan R
    Front Chem; 2021; 9():775226. PubMed ID: 34976949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondrial RNA polymerase in acute myeloid leukemia.
    Bralha FN; Liyanage SU; Hurren R; Wang X; Son MH; Fung TA; Chingcuanco FB; Tung AY; Andreazza AC; Psarianos P; Schimmer AD; Salmena L; Laposa RR
    Oncotarget; 2015 Nov; 6(35):37216-28. PubMed ID: 26484416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.
    Greer YE; Hernandez L; Fennell EMJ; Kundu M; Voeller D; Chari R; Gilbert SF; Gilbert TSK; Ratnayake S; Tang B; Hafner M; Chen Q; Meerzaman D; Iwanowicz E; Annunziata CM; Graves LM; Lipkowitz S
    Cancer Res Commun; 2022 Oct; 2(10):1144-1161. PubMed ID: 36388465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLRMT regulates the switch between replication primer formation and gene expression of mammalian mtDNA.
    Kühl I; Miranda M; Posse V; Milenkovic D; Mourier A; Siira SJ; Bonekamp NA; Neumann U; Filipovska A; Polosa PL; Gustafsson CM; Larsson NG
    Sci Adv; 2016 Aug; 2(8):e1600963. PubMed ID: 27532055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mitochondrial RNA polymerase: structure-function, mechanism and inhibition.
    Arnold JJ; Smidansky ED; Moustafa IM; Cameron CE
    Biochim Biophys Acta; 2012; 1819(9-10):948-60. PubMed ID: 22551784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule inhibitors of human mitochondrial DNA transcription.
    Bonekamp NA; Peter B; Hillen HS; Felser A; Bergbrede T; Choidas A; Horn M; Unger A; Di Lucrezia R; Atanassov I; Li X; Koch U; Menninger S; Boros J; Habenberger P; Giavalisco P; Cramer P; Denzel MS; Nussbaumer P; Klebl B; Falkenberg M; Gustafsson CM; Larsson NG
    Nature; 2020 Dec; 588(7839):712-716. PubMed ID: 33328633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
    Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
    Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Protease Targeting Chimeras for Mitochondrial Matrix Protein Degradation.
    Wang D; Wang W; Fang L; Qi L; Zhang Y; Liu J; Liang Y; Yang H; Wang M; Wei X; Jiang R; Liu Y; Zhou W; Fang X
    J Am Chem Soc; 2023 Jun; 145(23):12861-12869. PubMed ID: 37276358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer.
    Cormio A; Sanguedolce F; Pesce V; Musicco C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression.
    Wang Z; Cotney J; Shadel GS
    J Biol Chem; 2007 Apr; 282(17):12610-8. PubMed ID: 17337445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLPP deficiency ameliorates neurodegeneration caused by impaired mitochondrial protein synthesis.
    Rumyantseva A; Popovic M; Trifunovic A
    Brain; 2022 Mar; 145(1):92-104. PubMed ID: 35240691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP.
    Fennell EMJ; Aponte-Collazo LJ; Wynn JD; Drizyte-Miller K; Leung E; Greer YE; Graves PR; Iwanowicz AA; Ashamalla H; Holmuhamedov E; Lang H; Karanewsky DS; Der CJ; Houry WA; Lipkowitz S; Iwanowicz EJ; Graves LM
    Pharmacol Res Perspect; 2022 Aug; 10(4):e00993. PubMed ID: 35929764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of energy metabolism during early mammalian development: TEAD4 controls mitochondrial transcription.
    Kumar RP; Ray S; Home P; Saha B; Bhattacharya B; Wilkins HM; Chavan H; Ganguly A; Milano-Foster J; Paul A; Krishnamurthy P; Swerdlow RH; Paul S
    Development; 2018 Oct; 145(19):. PubMed ID: 30201685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLRMT mutations impair mitochondrial transcription causing neurological disease.
    Oláhová M; Peter B; Szilagyi Z; Diaz-Maldonado H; Singh M; Sommerville EW; Blakely EL; Collier JJ; Hoberg E; Stránecký V; Hartmannová H; Bleyer AJ; McBride KL; Bowden SA; Korandová Z; Pecinová A; Ropers HH; Kahrizi K; Najmabadi H; Tarnopolsky MA; Brady LI; Weaver KN; Prada CE; Õunap K; Wojcik MH; Pajusalu S; Syeda SB; Pais L; Estrella EA; Bruels CC; Kunkel LM; Kang PB; Bonnen PE; Mráček T; Kmoch S; Gorman GS; Falkenberg M; Gustafsson CM; Taylor RW
    Nat Commun; 2021 Feb; 12(1):1135. PubMed ID: 33602924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase.
    Li X; Ze X; Zhou S; Hu Z; He C; Jia Y; Liu L; Wang T; Li J; Xu S; Yang DH; Chen ZS; Yao H; Xu J; Yao H
    J Med Chem; 2023 Apr; 66(7):5118-5153. PubMed ID: 36997840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.